Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

Clinical trial NCT06922903 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06922903
Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-04-01
Primary completion: 2026-05-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.